.jpg)
.png)
Treatment of the HIV-infected patient has evolved over the past decade into a prototype of how multidisciplinary team effort becomes an essential element in the practice of evidence-based medicine.
Prior to 1996, HIV-related mortality was >20% because of the disease itself but, since the advent of potent combination highly active antiretroviral therapy (HAART), the annual AIDS-related mortality is <2%.
Article By:
President-Elect, Midwest Lipid Association
Medical Director for Chronic Disease Management
Wheaton Franciscan Medical Group
Racine, WI
Diplomate, American Board of Clinical Lipidology
Cardiovascular disease (CVD) remains the leading cause of mortality in those > 75 years of age.1 In the United States, an estimated 84 million people have CVD, with approximately 50% of these Americans being ≥ 60 years old.2 The prevalence of CVD increases with age, from 15% in men and 9% in women between the ages of 20 and 39 to 79% in men and 85% in women ages 80+.3 Although the CVD burden is noted to be high in this subset of individuals, most studies
Article By:
Cardiology Fellow
Division of Cardiology
Loyola University Medical Center
Maywood, IL
Assistant Professor of Medicine and Public Health Sciences
Division of Cardiology
Director, Preventive Cardiology and Lipid Program
Loyola University Medical Center
Maywood, IL
Chronic kidney disease (CKD) has been established as an independent risk factor for cardiovascular disease.1 The data from multiple studies link a decrease in glomerular filtration rate (GFR) and/ or proteinuria with increased risk for cardiovascular disease.2-4 Dyslipidemia likely plays a significant role in the pathophysiology of cardiovascular disease.
Article By:
Assistant Clinical Professor,
University of Illinois at Chicago
Internal Medicine Program Director
Advocate Christ Medical Center
Oak Lawn, IL
Clinical Professor of Medicine
Section of Nephrology
University of Illinois at Chicago College of Medicine
Associates in Nephrology, SC
Chicago, IL
Definition of Metabolic Syndrome
Article By:
Diplomate, American Board of Clinical Lipidology
Physician, Preventive Vascular Services
Vascular Health Center, Fairview Southdale Hospital
Edina, MN
Professor of Medicine; Donald and Patricia Garofalo Chair in Preventive Cardiology;
Cardiovascular Division, Medical School, and Adjunct Professor Epidemiology and
Community Health, School of Public Health, University of Minnesota
Cardiologist at University of Minnesota Medical Center, Fairview
Minneapolis, MN
What will it take to lower your patient’s risk of heart attack and stroke? Can we improve on previous risk prediction tools? Can we address global cardiovascular disease risk better in women and African Americans? Can we initiate atherosclerotic cardiovascular disease (ASCVD) risk reduction with evidence based "proven" therapy?
Article By:
Bonow Professor of Medicine
Feinberg School of Medicine
Northwestern University
Chicago, IL
President, Foundation of the National Lipid Association
Associate Professor of Medicine
Washington University School of Medicine
St. Louis, MO
Diplomate, American Board of Clinical Lipidology
Professor of Medicine/Cardiology
David Geffen School of Medicine at UCLA
Co-director, UCLA Program in Preventive Cardiology Director
UCLA Barbra Streisand Women’s Heart Health Center
Los Angeles, CA
South Asians are defined as individuals who derive their ethnic origin from the Indian subcontinent.
Article By:
Medical Director
South Asian Cardiovascular Center
Division of Cardiovascular Disease
Advocate Lutheran General Hospital
Park Ridge, IL
Advocate Lutheran General Hospital
Park Ridge, IL
It is with great pleasure that we bring you this issue focusing on Clinical Conundrums in Special Populations. As Dr. Ito mentions in his Presidents Message the NLA has been very busy this year. In an effort to help clinical lipidologists we convened a panel of Clinical Lipidology experts to provide guidance given the plethora of guidelines now available regarding management of dyslipidemia.
Article By:
Clinical Epidemiology and Biostatistics and
Clinical Lipidology Professor
Oklahoma University Health Sciences Center
Oklahoma City, OK
Diplomate, American Board of Clinical Lipidology
When the task of writing the quarterly Lipid Spin was announced at our Board meeting, the vast geographical 11 state volunteers immediately responded. The knowledge, talent, skills and passion expressed show the commitment and specialized expertise of the membership. Their enthusiasm for participating in this issue showed their commitment to educating health providers and patients.
Article By:
President, Midwest Lipid Association
Trinity Medical Group
Minot, ND
President-Elect, Midwest Lipid Association
Wheaton Franciscan Medical Group
Racine, WI
It has been my distinct pleasure to serve as President of the National Lipid Association (NLA) during the 2013/2014 term. I am thankful to have been a part of the leadership in an organization with so many dedicated colleagues. I was blessed to serve with a wonderful Executive Committee and surrounded by loyal friends, colleagues, and NLA staff.
Article By:
National Lipid Association President
Professor of Pharmacy Practice
Oregon State University/Oregon Health and Science University
Portland, OR
Special Education Session at the Orlando 2014 Annual Scientific Sessions:
The National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia
Friday, May 2 • 6:45 – 7:45 a.m.